Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „lead“
Suchtreffer
Begriffe & Kennungen
5'-Nicht-translatierte Regionen
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · Severe hypoglycaemic attacks, especially if recurrent, may lead to neurological damage. Prolonged or severe hy
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · Severe hypoglycaemic attacks, especially if recurrent, may lead to neurological damage. Prolonged or severe hy
Eintrag öffnenAdenuric · 4.5 · Inducers of glucuronidation Potent inducers of UGT enzymes might possibly lead to increased metabolism and dec
Eintrag öffnenAdenuric · 4.5 · Inducers of glucuronidation Potent inducers of UGT enzymes might possibly lead to increased metabolism and dec
Eintrag öffnenAlli (previously Orlistat GSK) · 4.8 · Not known Oxalate nephropathy that may lead to renal failure Hepatobiliary disorders
Eintrag öffnenAlli (previously Orlistat GSK) · 4.8 · †It is plausible that treatment with orlistat can lead to anxiety in anticipation of or secondary to gastroint
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAprovel · 4.5 · As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk
Eintrag öffnenAzacitidine Mylan · 4.8 · 10 Three subjects experienced a treatment emergent event leading to drug discontinuation (pyrexia, disease pro
Eintrag öffnenAzacitidine Mylan · 4.8 · Infections Myelosuppression may lead to neutropenia and an increased risk of infection. Serious adverse reacti
Eintrag öffnenBalversa · 4.8 · Adverse reactions leading to dose reduction occurred in 59.7% of patients. Stomatitis (15.4%), palmar-plantar
Eintrag öffnenBalversa · 4.8 · Adverse reactions leading to treatment discontinuation occurred in 19.4% of patients. Detachment of retinal pi
Eintrag öffnenBavencio · 4.8 · 17 Immune-mediated nephritis did not lead to discontinuation of avelumab in any patient. All 2 patients with i
Eintrag öffnenBavencio · 4.8 · Immune-mediated adrenal insufficiency did not lead to discontinuation of avelumab in any patient. Eight (88.9%
Eintrag öffnenBavencio · 4.8 · Immune-mediated pneumonitis did not lead to discontinuation of avelumab in any patient. All 3 patients with im
Eintrag öffnen